Építés alatt – nem éles oldal
Belépés

NCT06493357Toboroz

Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi

UNCPM 22401 - Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model for the Elimination of Mother-to-Child Transmission of HIV in Lilongwe and Mangochi, Malawi

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. szept. 18.

Következő lépések

Rövid összefoglaló (regiszter, angolul)

Purpose: To conduct a hybrid effectiveness-implementation stepped-wedge trial to: 1. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of infants who receive timely EID testing. 2. Estimate the effect of the PAC-Man model, compared to SOC, on the proportion of pregnant and breastfeeding women living with HIV who receive guideline-adherent viral load testing. 3. Compare implementation outcomes between the PAC-Man model and SOC. Participants: The total study sample size is 2,426, including 2,304 mother-infant pair (MIP) survey participants, 48 high-risk pregnant/breastfeeding women living with HIV for in-depth interviews (from high-risk MIPs who participated in a survey); 10 PMTCT policy makers and Ministry of Health (MOH)/ President's Emergency Plan for AIDS Relief (PEPFAR) implementing partner senior managers for key informant interviews; and about 48-64 professional and lay health providers for focus group discussions and implementation actor surveys. To rigorously evaluate the PAC-Man model, investigators will use a hybrid (type 3) effectiveness-implementation incomplete stepped-wedge trial design. The hybrid incomplete stepped-wedge design is a rigorous quasi-experimental design that allows for incremental "rollout" of the PAC-Man model and serial measurement of both health outcomes (for infants and mothers in Objectives 1 and 2, respectively), as well as implementation outcomes (Objective 3). The incomplete stepped-wedge design is more efficient than a complete design, minimizes costs, and reduces participant burden, without sacrificing statistical precision. Using this design, sequential crossover from control (i.e., the SOC) to intervention (i.e., SOC plus the PAC-Man model) takes place at each 'step' using cluster randomization until all clusters (defined as a group of "sites," or health facilities plus the surrounding communities in its catchment area) receive the intervention. The 12 sites included in our study will be divided into 4 clusters of 3 sites each.

Állapot (regiszter)
Toboroz
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
2426 (tervezett)
Első benyújtás
2024. jún. 26.
Kezdés
2025. márc. 27.
Elsődleges befejezés
2028. márc. 31.
Fő szponzor
University of North Carolina, Chapel Hill
Betegségek
HIV-fertőzés
NCT-szám
NCT06493357

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Tervezett résztvevők: 2426
  • 2025. márc. 27. és az elsődleges befejezés (2028. márc. 31.) között
  • 3 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • Documented transferred out from a site prior to the field survey.
  • Participated previously in the field survey.

Egyéb

  • None.
    • The criteria for Enumerated MIP Field Survey is as follows:
  • Decline informed consent.
    • The criteria for In-Depth Interviews is as follows:
  • Decline informed consent.
    • The criteria for Focus Group Discussions is as follows:
  • Decline informed consent.
    • The criteria for Key Informant Interviews is as follows:
  • Decline informed consent.
    • The criteria for Implementation Actor Questionnaires is as follows:
  • Decline informed consent.

Kiket keres a vizsgálat

  • Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey.
  • Age 16 years or older.
  • Enrolled in the national EMTCT program at a study site in the 12 months preceding a survey.
  • Age 16 years or older.
  • Met high-risk criteria for PAC-Man model.
  • Participated in a field survey.
  • Age 18 years or older.
  • MOH or implementing partner professional or lay health worker at a study site (such as nurses, community health workers, health surveillance assistants, and HIV diagnostic assistants)
  • Generally familiar with the PAC-Man model and/or EMTCT/ EID service delivery at their site.
  • Age 18 years or older.
  • HIV/ EMTCT policy maker OR MOH/ PEPFAR implementing partner senior manager.
  • Generally familiar with HIV and/or EMTCT/ EID service delivery.
  • Age 18 years or older.
  • Professional or lay health provider at a study site.
  • Generally familiar with HIV and/or EMTCT/ EID service delivery at their site.
  • Participated in a focus group discussion.

A regiszterben nem jelölt feltételek

  • The criteria for Enumerated MIP Cohort is as follows:

Életkor a regiszterben: 16 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (3)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Area 18 Health CentreLilongweMalawiToboroz
Bwaila HospitalLilongweMalawiToborzás még nem indult
Monkey Bay Community HospitalMonkey BayMalawiToboroz

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.